Olaparib is under clinical development by AstraZeneca and currently in Phase II for Malignant Mesothelioma. According to GlobalData, Phase II drugs for Malignant Mesothelioma have a 42% phase ...

Brazilian President Luiz Inacio Lula is showing "progressive improvement" following surgery three weeks ago to stop an intracranial hemorrhage, his doctors said after a hospital check-up scan on ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Nearly two dozen women across the nation have filed lawsuits against a pharmaceutical giant over a contraceptive linked to a ...

China’s National Medical Products Administration (NMPA) has recently approved Zorifer (zorifertinib), an oral epidermal ...

Brazilian President Luiz Inacio Lula is showing "progressive improvement" after surgery three weeks ago to stop an ...

Australian class action lawyers are investigating whether a female contraception injection is linked to brain tumours.

Lenvatinib plus pembrolizumab did not improve PFS or OS over chemotherapy in patients with advanced or recurrent endometrial ...

Cilag’s Rybrevant in combo with Lazcluze for first-line treatment of patients with EGFR-mutated advanced NSCLC: Beerse, Belgium Tuesday, Dec ...

Cancer epidemiologists have said the study should not worry ... The type of tumour is called an intracranial meningioma, ...

"This advanced equipment will allow for targeted cancer treatment, focusing on destroying malignant ... safeguarding against severe complications such as shock, intracranial haemorrhage, joint damage, ...